Medical Director, US Medical Affairs - Oncology (TGCT)

The businesses of Merck KGaA, Darmstadt, Germany•Boston, MA

About The Position

The Medical Director for TGCT (Tenosynovial Giant Cell Tumor), US Medical Affairs, is responsible for working closely with the Vice President Medical Strategy, Oncology & N&I of US Medical Affairs, to develop strategic planning and oversee the execution of medical activities focusing on the development and execution of peri-launch medical plans for pimicotinib. The Medical Director directly partners with core medical team members from Field Medical Affairs, Medical Communications, Medical Information, and HEOR while collaborating cross-functionally with business partners from commercial, Global Medical Affairs, and R&D. The Medical Director will be cognizant of Oncology Key Thought Leaders (KTLs) in the relevant indication and will have the credibility to develop strong medical-scientific relationships. The Medical Director will address the needs of the evolving TGCT landscape and must contribute value to our assets in the healthcare system by leading strategic data generation and dissemination through appropriate peer-reviewed and peer-to-peer channels. The Medical Director must specifically understand the key decision drivers of relevant external stakeholders (patients, medical experts (KTLs), payors, etc.) and develop matching programs and data. The Medical Director must have expertise in oncology, specifically in relevant oncology indications, particularly Sarcoma, with a strong track record of executing medical affairs plans in rare tumor landscapes. The Medical Director will work closely with the Vice President Medical Strategy, Oncology & N&I NA Medical Affairs to set direction, implement strategy, and ensure delivery of medical activities related to TGCT/pimicotinib.

Requirements

Advanced scientific degree (e.g., PharmD, PhD, DO, MD) required; MD preferred.
Minimum of 5 years in the pharmaceutical/healthcare industry with a demonstrated record of successful results.
Prior experience of at least 2 years in Rare Tumors/Rare disease Medical Affairs required.
Willingness to travel up to 40%.

Nice To Haves

Prior successful product launch experience in the rare disease landscape is a definite advantage.
Ability to communicate openly and share information to foster trust while encouraging constructive debate, making informed decisions, and ensuring shared commitment to outcomes.
Demonstrated willingness to take risks and stand up for what is right while prioritizing the needs and experiences of customers and patients in all decisions.
Demonstrated understanding of the clinical development and post-marketing environment for pharmaceuticals, including post-marketing clinical studies and medical affairs strategic initiatives in Oncology.
Excellent management, teamwork, communication, and presentation skills, with solid experience in developing strategic plans and oversight processes.
Demonstrated ability to work with teams, manage a diverse workgroup, motivate them, and maximize productivity.
Experience in creating and overseeing cross-functional and multi-disciplinary teams.
Experience influencing medical field teams in changing competitive environments, product technology, and evolving needs.
Experience working in a matrix environment that integrates all business unit functions.
Demonstrated orientation and credibility with internal and external customers.
Ability to create solid plans and reports for measurable performance and progress evaluation.
Knowledge and application of business planning and leadership principles, including goal setting, action plans, monitoring tools, and techniques to develop and implement action plans.
Strong budget management experience and knowledge.
Commitment to setting and reaching ambitious goals and setting high standards while acting in the best interest of the company and taking initiative to drive results.
Uphold ethical standards and being honest in all interactions.
Ability to streamline processes to focus on what matters and creates impact and acting quickly to adapt to changes.
Demonstrated ability to embrace new ideas, challenge the status quo, and seek innovative solutions while valuing diverse perspectives and treating others with respect and dignity.

Responsibilities

Ensure timely delivery of key US Medical Affairs plans specific to TGCT/pimicotinib, proactively define and track medical metrics and corporate objectives in a highly dynamic environment.
Develop and implement relevant strategies, tactics, and programs to accomplish US Medical Affairs Oncology objectives.
Set, track, and provide status updates on US Medical Affairs Oncology programs, budgets, and related processes within the department.
Develop and execute all aspects of KTL engagement as appropriate.
Provide scientific and medical perspectives to inform clinical and commercial development strategies, patient advocacy, publication strategies, medical communications, and identification of strategically impactful evidence generation programs.
Provide program management support in the development, communication, and implementation of US Medical Affairs programs, policies, and procedures.
Represent Oncology Medical Affairs in internal and external medical meetings and committees.
Contribute to the development of Oncology Medical Affairs training materials.
Collaborate with other therapeutic areas to leverage US Medical Affairs Oncology expertise and programs as appropriate.
Ensure collaboration between US Medical Affairs Oncology, including HEOR, Global Medical Affairs, Clinical Development, and other functions within the CMO organization.
Align goals and objectives with cross-functional strategic partners. Work closely with the US Medical Field Team, contributing to their planning, strategy, tactics, and education.
Provide reporting and information to the US Medical Affairs Oncology team to track progress against plans.